A Joint Clinical Research Collaboration among ACT Genomics, Kaohsiung Medical University (KMU), and National Health Research Institutes (NHRI) Seeks to Investigate the Genomic Landscape of Melanoma in Taiwan

2020-06-20

ACT Genomics, Kaohsiung Medical University (KMU), and National Health Research Institutes (NHRI) launched a joint clinical research collaboration aimed to establish comprehensive genomic profiles of Melanoma within the Taiwanese population. This study utilizes next-generation sequencing (NGS) technology to investigate biomarkers associated with melanoma and is expected to lead to future development of safer and more effective treatment as well as new methods for diagnosis.

Image title

Image title